Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 189.70
-2.05 (-1.07%)
At close: Aug 8, 2025
Piramal Pharma Revenue
Piramal Pharma had revenue of 19.34B INR in the quarter ending June 30, 2025, a decrease of -0.89%. This brings the company's revenue in the last twelve months to 91.34B, up 9.08% year-over-year. In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B with 11.99% growth.
Revenue (ttm)
91.34B
Revenue Growth
+9.08%
P/S Ratio
2.76
Revenue / Employee
16.68M
Employees
5,476
Market Cap
252.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 91.51B | 9.80B | 11.99% |
| Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
| Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
| Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
| Mar 31, 2021 | 58.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |